Abstract
The impact of cancer on a population may be measured in several ways. Incidence, relative survival and mortality are frequently utilized for this purpose. Incidence and relative survival are, however, often influenced by changes in the diagnostics of incident cancer, particularly by an altered rate of detection of non-fatal cancer. Mortality, as traditionally studied, is often influenced by changes of death causes diagnostics or of cocling routines.
In an attempt to overcome some of these difficulties, the concept of excess mortality was suggested, which is independent of death cause diagnoses or cocling routines, as well as of the rate of detection of non-fatal cancer. In order to elucidate time trends in the overall effects of cancer we analysed incidence, survival and mortality from all cancer in the northern region of Sweden 1960—1986. An increasing age-adjusted cancer incidence was paralleled by an improvement in relative survival, whereas age-adjusted cancer mortality was mainly unchanged, at least when studied as excess mortality.
We interpreted these finclings as due mainly to an increased detection of non-fatal cancer, and to an unchanged occurrence rate of fatal cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Enstrom J E, Austin D F: Interpreting cancer survival rates. The available data on survival are not a sensitive measure of progress in cancer control.Science 195, 847 (1977).
Bailar III J C, Smith E M: Progress against cancer?New Engl J Med 314, 1226 (1986).
Gori G B, Lynch C J: Decline of U.S. cancer mortality rates: expert estimates of past underreporting.Regul Toxicol Pharmacol 6, 261 (1986).
Adami H-O, Sparén P, Bergström R, Holmberg L, Krusemo U-B, Pontén J: Increasing survival trend after cancer diagnosis in Sweden 1960-1984.J Nat Cancer lust 81, 1640 (1989).
Doll R Progress against cancer: are we winning the war?Ada Oncol 28, 611 (1989).
Rutqvist L E, Mattsson B, Signomklao T: Cancer mortality trends in Sweden 1960—1986.Acta Oncol 28, 771 (1989).
Zajicek G: Progress against cancer: are we winning the war?Cancer J 3, 2 (1990).
Doll R, Peto R: The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today.J Nat Cancer Inst 66, 1191 (1981).
Ederer F, Axtell L M, Cutler S J: National Cancer Institute Monograph No. 6, pp. 101–121. National Institutes of Health, Bethcsda, U.S.A. (1961).
Hakulinen T: Cancer survival corrected for hetero geneity in patient withdrawal.Biometrics 38, 933 (1982).
Lenner P: The excess mortality rate. A useful concept in cancer epidemiology.Acta Oncol 29, 573 (1990).
Breslow N, Chan C W, Dhom G, Drury R A B, Franks L M, Gellei B, Lee Y S, Lundberg S, Sparke B, Sternby N H, Tulinius H: Latent carcinoma of prostate at autopsy in seven areas.Int J Cancer 20., 680 (1977).
Carter H B, Piantadosi S, Isaacs J T: Clinical evidence for and implications of the multistep development of prostate cancer.J Urol 143, 742 (1990).
The Swedish National Board of Health and Welfare. The Cancer Registry: Cancer Incidence in Sweden 1986. Stockholm, National Board of Health and Welfare (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lenner, P., Jonsson, H. & Gardfjel, O. Trends in cancer incidence, survival and mortality in northern sweden 1960-1986. Med. Oncol. & Tumor Pharmacother. 8, 105–112 (1991). https://doi.org/10.1007/BF02988862
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02988862